Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On April 16, 2026, Steven C. Gilman, a member of the Board of Directors (the "Board") of SCYNEXIS, Inc. (the "Company"), notified the Company of his intent to retire as a member of the Board and therefore not stand for reelection at the Company's 2026 annual meeting of stockholders (the "2026 Annual Meeting"). Accordingly, Dr. Gilman's term as a director will end when his current term expires at the 2026 Annual Meeting. Dr. Gilman will remain in his roles as the Chair of the Compensation Committee and a member of the Nominating and Corporate Governance Committee of the Board until the conclusion of the 2026 Annual Meeting. The Company's management and the Board thank Dr. Gilman for his years of service and valuable contributions to the Company.

Dr. Gilman's resignation was not the result of any disagreement with the Company on any matter related to the Company's operations, policies, practices or strategy, the Company's management or the Board.